Main procedure autologous transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy19

Hematopoietic Stem Cells Bone Marrow Cells, Cultured Bone Marrow Cells Stem Cells T-Lymphocytes Transplants Antilymphocyte Serum Liver T-Lymphocytes, Cytotoxic Lymphocytes Portal Vein Dendritic Cells Kidney Fetal Blood Mesenchymal Stromal Cells CD4-Positive T-Lymphocytes Clone Cells Killer Cells, Natural

Organisms7

Transplantation Chimera Lentivirus Rabbits Mice, Inbred C57BL Rats, Inbred Lew Mice, Inbred BALB C Mice, SCID

Diseases42

Multiple Myeloma Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hodgkin Disease Hematologic Neoplasms Neoplasm, Residual Lymphoma Postoperative Complications Leukemia Leukemia, Myeloid, Acute Myelodysplastic Syndromes Liver Failure Neoplasm Recurrence, Local Disease Progression Cadaver Liver Diseases Acute Disease Kidney Failure, Chronic Anemia, Aplastic Cytomegalovirus Infections Bronchiolitis Obliterans Disease Models, Animal Blood Group Incompatibility Infection Precursor Cell Lymphoblastic Leukemia-Lymphoma End Stage Liver Disease Hematologic Diseases Leukemia, Myeloid Brain Death Liver Cirrhosis Hepatic Veno-Occlusive Disease Chronic Disease Liver Failure, Acute Liver Neoplasms Neoplasms Lymphoproliferative Disorders Leukemia, Myelogenous, Chronic, BCR-ABL Positive Primary Graft Dysfunction Biliary Atresia Delayed Graft Function Ischemia

Chemicals and Drugs36

Melphalan Antigens, CD34 Carmustine Granulocyte Colony-Stimulating Factor Cyclophosphamide Etoposide Busulfan Immunosuppressive Agents Cytarabine Myeloablative Agonists Thalidomide Kanamycin Kinase Vincristine Idarubicin Prednisone Antineoplastic Agents, Alkylating Dexamethasone Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Doxorubicin Antineoplastic Agents Antigens, CD Cyclosporine Tacrolimus Recombinant Proteins HLA Antigens Antilymphocyte Serum Thiotepa Mycophenolic Acid Antigens, Neoplasm ABO Blood-Group System Vidarabine Isoantibodies Biological Markers Isoantigens Interleukin-2

Analytical, Diagnostic and Therapeutic Techniques and Equipment100

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Kidney Transplantation Hematopoietic Stem Cell Mobilization Treatment Outcome Peripheral Blood Stem Cell Transplantation Combined Modality Therapy Cell Transplantation Heart Transplantation Salvage Therapy Lung Transplantation Bone Marrow Purging Leukapheresis Antineoplastic Combined Chemotherapy Protocols Whole-Body Irradiation Remission Induction Retrospective Studies Disease-Free Survival Survival Analysis Organ Transplantation Blood Transfusion, Autologous Follow-Up Studies Survival Rate Pancreas Transplantation Islets of Langerhans Transplantation Transplantation Feasibility Studies Prognosis Blood Component Removal Transplantation, Isogeneic Cell Separation Transplantation, Heterotopic Prospective Studies Genetic Therapy Cord Blood Stem Cell Transplantation Heart-Lung Transplantation Colony-Forming Units Assay Immunomagnetic Separation Blood Cell Count Cell Culture Techniques Immunosuppression Transduction, Genetic Histocompatibility Testing Skin Transplantation Flow Cytometry Fetal Tissue Transplantation Mesenchymal Stem Cell Transplantation Multivariate Analysis Tissue Transplantation Transplantation, Heterologous Corneal Transplantation Risk Factors Polymerase Chain Reaction Brain Tissue Transplantation Facial Transplantation Donor Selection Organ Preservation Tissue and Organ Harvesting Postoperative Period Lymphocyte Culture Test, Mixed Patient Selection Reoperation Lymphocyte Activation Disease Models, Animal Biopsy Actuarial Analysis Anastomosis, Surgical Bone Transplantation Lymphocyte Transfusion Hand Transplantation Neoplasm Transplantation Reconstructive Surgical Procedures Models, Animal Postoperative Care Incidence Lymphocyte Depletion Fatal Outcome Risk Assessment Blood Transfusion Cryopreservation Kaplan-Meier Estimate Cohort Studies Immunotherapy, Adoptive Preoperative Care Immunotherapy Immunophenotyping Surgical Procedures, Operative Hepatectomy Severity of Illness Index Pilot Projects Immunohistochemistry Leukocyte Count Tissue Preservation Tissue Engineering Platelet Count

Phenomena and Processes21

Graft Survival Time Factors Graft Rejection Transplantation Immunology Graft vs Tumor Effect Hematopoiesis Blood Cell Count Genetic Vectors Transplantation Tolerance Transduction, Genetic Cell Differentiation Histocompatibility Cytotoxicity, Immunologic Lymphocyte Activation Chimerism Immune Tolerance Graft vs Leukemia Effect Regeneration Leukocyte Count Recovery of Function Platelet Count

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture1

Tissue Engineering

Information Science3

Survival Rate Incidence Fatal Outcome

Named Groups2

Tissue Donors Living Donors

Health Care26

Treatment Outcome Retrospective Studies Disease-Free Survival Survival Analysis Follow-Up Studies Survival Rate Feasibility Studies Prospective Studies Tissue and Organ Procurement Multivariate Analysis Waiting Lists Risk Factors Donor Selection Postoperative Period Patient Selection Actuarial Analysis Postoperative Care Incidence Fatal Outcome Risk Assessment Kaplan-Meier Estimate Cohort Studies Preoperative Care Age Factors Severity of Illness Index Pilot Projects

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Multiple Myeloma Kidney Transplantation Melphalan Hematopoietic Stem Cell Mobilization Treatment Outcome Graft Survival Peripheral Blood Stem Cell Transplantation Combined Modality Therapy Cell Transplantation Heart Transplantation Lymphoma, Non-Hodgkin Salvage Therapy Antigens, CD34 Lung Transplantation Bone Marrow Purging Recurrence Carmustine Leukapheresis Graft vs Host Disease Granulocyte Colony-Stimulating Factor Cyclophosphamide Antineoplastic Combined Chemotherapy Protocols Whole-Body Irradiation Remission Induction Hematopoietic Stem Cells Retrospective Studies Disease-Free Survival Survival Analysis Organ Transplantation Time Factors Etoposide Busulfan Hodgkin Disease Blood Transfusion, Autologous Hematologic Neoplasms Graft Rejection Follow-Up Studies Survival Rate Immunosuppressive Agents Pancreas Transplantation Islets of Langerhans Transplantation Cytarabine Tissue Donors Transplantation Immunology Transplantation Graft vs Tumor Effect Myeloablative Agonists Transplantation Chimera Thalidomide Bone Marrow Kanamycin Kinase Feasibility Studies Prognosis Blood Component Removal Transplantation, Isogeneic Vincristine Cells, Cultured Neoplasm, Residual Lymphoma Living Donors Cell Separation Transplantation, Heterotopic Hematopoiesis Prospective Studies Genetic Therapy Cord Blood Stem Cell Transplantation Idarubicin Postoperative Complications Prednisone Bone Marrow Cells Leukemia Heart-Lung Transplantation Antineoplastic Agents, Alkylating Dexamethasone Leukemia, Myeloid, Acute Stem Cells Colony-Forming Units Assay Myelodysplastic Syndromes Immunomagnetic Separation Blood Cell Count Cell Culture Techniques Genetic Vectors Immunosuppression Tissue and Organ Procurement Transplantation Tolerance Transduction, Genetic Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Histocompatibility Testing Lentivirus Doxorubicin Skin Transplantation Antineoplastic Agents

No FAQ available that match "main procedure autologous transplantation"